Stock 2005 SSY GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company SSY Group Limited

Equities

2005

KYG8406X1034

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:09 2024-04-25 am EDT 		5-day change 1st Jan Change
4.74 HKD -0.42% Intraday chart for SSY Group Limited -1.66% -4.05%
Apr. 23 SSY Group Get Production, Registration Approval for Pneumonia Drug from Chinese Regulator MT
Apr. 16 SSY Group Logs Nearly 15% Boost in Q1 Profit MT

Business Summary

SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Number of employees: 5,640

Sales per Business

HKD in Million2022Weight2023Weight Delta
Intravenous Infusion Solution and Others
97.5 %
6,262 97.3 % 6,301 97.5 % +0.63%
Medical Materials
2.5 %
172 2.7 % 162 2.5 % -6.09%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
89.8 %
5,542 86.1 % 5,801 89.8 % +4.68%
Other Countries
10.2 %
892 13.9 % 662 10.2 % -25.81%

Managers

Managers TitleAgeSince
Ji Guang Qu CEO
 Chief Executive Officer 70 -
Hing Yeung Chow DFI
 Director of Finance/CFO 45 15-03-31
Guo Meng BRD
 Director/Board Member 50 -

Members of the board

Members of the board TitleAgeSince
Ji Guang Qu CEO
 Chief Executive Officer 70 -
Yi Bing Wang BRD
 Director/Board Member 61 07-07-25
Kwok Wai Chow BRD
 Director/Board Member 57 05-10-15
Hing Yeung Chow DFI
 Director of Finance/CFO 45 15-03-31
Xue Jun Su BRD
 Director/Board Member 56 14-12-14
Guang Ce Jiang BRD
 Director/Board Member 53 22-12-31
Guo Meng BRD
 Director/Board Member 50 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,969,043,000 1,220,199,385 ( 41.10 %) 0 41.10 %

Shareholders

NameEquities%Valuation
Ji Guang Qu
37.65 %
1,117,706,000 37.65 % 737 M $
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
20.43 %
606,722,000 20.43 % 400 M $
UBS Asset Management (Hong Kong) Ltd.
7.345 %
218,062,513 7.345 % 144 M $
Xue Jun Su
0.8224 %
24,416,000 0.8224 % 16 M $
UBS SDIC Fund Management Co., Ltd.
0.6940 %
20,604,000 0.6940 % 14 M $
Guo Meng
0.6736 %
20,000,000 0.6736 % 13 M $
Fullgoal Fund Management Co., Ltd.
0.5410 %
16,062,000 0.5410 % 11 M $
Wanjia Asset Management Co., Ltd.
0.4320 %
12,826,000 0.4320 % 8 M $
Bosera Asset Management Co., Ltd.
0.3526 %
10,468,000 0.3526 % 7 M $
Hamon Asian Advisors Ltd.
0.2405 %
7,140,000 0.2405 % 5 M $

Holdings

NameEquities%Valuation
CISEN PHARMACEUTICAL CO., LTD.
6.14%
 27,661,441 6.14% 54,959,687 $

Company contact information

SSY Group Ltd.

Rooms 4902-03, 49th Floor Central Plaza

, Hong Kong

+

http://www.ssygroup.com.hk
address SSY Group Limited(2005)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for SSY Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.74 HKD
Average target price
6.227 HKD
Spread / Average Target
+31.36%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SSY GROUP LIMITED Stock SSY Group Limited
-4.05% 1.8B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.06% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.18% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.75% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-11.69% 149B
AMGEN INC. Stock Amgen Inc.
-6.02% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 2005 Stock
  4. Company SSY Group Limited